Xin Hu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Neuropathic Pain

Respiratory Syndrome Coronavirus

Top Venues

ACS pharmacology & translational science

Molecular cancer therapeutics

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Hu, Paul Shinn, Zina Itkin, Lin Ye, Ya-Qin Zhang, Min Shen, Stephanie Ford-Scheimer, Matthew D Hall
A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug Discovery. ACS pharmacology & translational science 7 (8) (2024)
Xin Hu, Paul Shinn, Zina Itkin, Lin Ye, Ya-Qin Zhang, Min Shen, Stephanie Ford-Scheimer, Matthew D Hall
A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug Discovery. ACS pharmacology & translational science 7 (8) (2024)
Sitanshu S Singh, Raul Calvo, Anju Kumari, Rushikesh V Sable, Yuhong Fang, Dingyin Tao, Xin Hu, Sarah Gray Castle, Saifun Nahar, Dandan Li, Emily Major, Tino W Sanchez, Rintaro Kato, Xin Xu, Jian Zhou, Liang Liu, Christopher A LeClair, Anton Simeonov, Bolormaa Baljinnyam, Mark J Henderson, Juan Jose Marugan, Rushikesh Sable
Fatty acid derivatization and cyclization of the immunomodulatory peptide RP-182 targeting CD206high macrophages improves anti-tumor activity. Molecular cancer therapeutics (2024)
Xin Hu, Catherine Z Chen, Miao Xu, Zongyi Hu, Hui Guo, Zina Itkin, Paul Shinn, Parker Ivin, Madeleine Leek, T Jake Liang, Min Shen, Wei Zheng, Matthew D Hall
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein. ACS medicinal chemistry letters 12 (8) (2021)
Xin Hu, Jonathan H Shrimp, Hui Guo, Miao Xu, Catherine Z Chen, Wei Zhu, Alexey V Zakharov, Sankalp Jain, Paul Shinn, Anton Simeonov, Matthew D Hall, Min Shen
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS pharmacology & translational science 4 (3) (2021)